Stuart A. Aaronson

Last updated
Stuart A. Aaronson
Nci-vol-8199-300 Stuart Aaronson.jpg
Born (1942-02-28) February 28, 1942 (age 81)
Mount Clemens, Michigan
Education UC Berkeley, UC SF
Occupation Biologist
Employer The Mount Sinai Hospital
Known for Cancer research
TitleJane B. and Jack R. Aron Professor of Neoplastic Diseases and Founding Chair Emeritus of Oncological Sciences

Stuart A. Aaronson (born February 28, 1942) is an American author and cancer biologist. [1] [2] He has authored more than 500 publications and holds over 50 patents, and was the Jane B. and Jack R. Aron Professor of Neoplastic Diseases and Chairman of Oncological Sciences at The Mount Sinai Hospital in New York City until March 2013, when he assumed the title of Founding Chair Emeritus of the Department of Oncological Sciences. [3] The current Chairman of Oncological Sciences is Ramon E. Parsons.

Contents

Biography

Aaronson graduated summa cum laude from the University of California, Berkeley, in 1962, with a degree in chemistry. He earned his M.D. from the University of California, San Francisco Medical Center in 1966, and completed a fellowship at the University of Cambridge in England and an internship in medicine at Moffitt Hospital in San Francisco. [3]

In 1967, Aaronson joined the National Institutes of Health as a Senior Staff Fellow. He headed the Molecular Biology Section of the Viral Carcinogenesis Branch from 1970 until 1977, after which he became Chief of the Laboratory of Cellular and Molecular Biology at the National Cancer Institute, until 1993, when he was named Chairman of Oncological Sciences at The Mount Sinai Hospital.

Research

Aaronson's early research established the transformation-competent but replication-defective nature of mammalian sarcoma viruses and molecularly cloned many of their oncogenes. [3] [4] His investigations of the v-sis oncogene established the first normal function of an oncogene and its role in growth factor signaling. [1] [2] His discovery of erbB2 as a v-erbB-related gene amplified in a human breast carcinoma and the demonstration of its transforming properties paved the way for targeted therapies directed against its product, [4] and his successful isolation of KGF (FGF7), a growth factor present in the epithelialization-phase of wound healing, led to Amgen's successful phase III clinical trial and FDA approval of KGF for treatment of mucositis. [5] [6] Current research includes investigations into the mechanisms by which tumor suppressor genes induce permanent growth arrest/senescence, the signaling pathways involved, and investigations of the autocrine and paracrine acting growth factors PDGF, KGF, HGF, and Wnt ligands. [3] To date 3 papers on which Stuart Aaronson is author have been retracted, and 2 papers on which he is author have received expressions of concern. [7]

Awards and honors

Patents

Partial list:

Patent NumberTitle
6479255 [8] Polynucleotides encoding human FRP and fragments thereof
6225088 [9] DNA encoding plasminogen-like growth factor (PLGF) and related embodiments
6228600 [10] Immunoassays for the alpha platelet-derived growth factor receptor
6403769 [11] Fusion proteins that include antibody and nonantibody portions
6566098 [12] DNA encoding truncated hepatocyte growth factor variants
6639060 [13] erbB-3 nucleic acids
6653084 [14] Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor
6660488 [15] Antibodies for the alpha platelet-derived growth factor receptor
6709842 [16] DNA encoding a growth factor specific for epithelial cells
6833132 [17] Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity

Publications

Partial list:

Related Research Articles

<span class="mw-page-title-main">Oncogene</span> Gene that has the potential to cause cancer

An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.

<span class="mw-page-title-main">Paracrine signaling</span>

Paracrine signaling is a form of cell signaling, a type of cellular communication in which a cell produces a signal to induce changes in nearby cells, altering the behaviour of those cells. Signaling molecules known as paracrine factors diffuse over a relatively short distance, as opposed to cell signaling by endocrine factors, hormones which travel considerably longer distances via the circulatory system; juxtacrine interactions; and autocrine signaling. Cells that produce paracrine factors secrete them into the immediate extracellular environment. Factors then travel to nearby cells in which the gradient of factor received determines the outcome. However, the exact distance that paracrine factors can travel is not certain.

Autocrine signaling is a form of cell signaling in which a cell secretes a hormone or chemical messenger that binds to autocrine receptors on that same cell, leading to changes in the cell. This can be contrasted with paracrine signaling, intracrine signaling, or classical endocrine signaling.

An Error has occurred retrieving Wikidata item for infobox Hepatocyte growth factor receptor is a protein that in humans is encoded by the MET gene. The protein possesses tyrosine kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor.

p53 upregulated modulator of apoptosis Protein-coding gene in the species Homo sapiens

The p53 upregulated modulator of apoptosis (PUMA) also known as Bcl-2-binding component 3 (BBC3), is a pro-apoptotic protein, member of the Bcl-2 protein family. In humans, the Bcl-2-binding component 3 protein is encoded by the BBC3 gene. The expression of PUMA is regulated by the tumor suppressor p53. PUMA is involved in p53-dependent and -independent apoptosis induced by a variety of signals, and is regulated by transcription factors, not by post-translational modifications. After activation, PUMA interacts with antiapoptotic Bcl-2 family members, thus freeing Bax and/or Bak which are then able to signal apoptosis to the mitochondria. Following mitochondrial dysfunction, the caspase cascade is activated ultimately leading to cell death.

<span class="mw-page-title-main">Transcription factor Jun</span> Mammalian protein found in Homo sapiens

Transcription factor Jun is a protein that in humans is encoded by the JUN gene. c-Jun, in combination with protein c-Fos, forms the AP-1 early response transcription factor. It was first identified as the Fos-binding protein p39 and only later rediscovered as the product of the JUN gene. c-jun was the first oncogenic transcription factor discovered. The proto-oncogene c-Jun is the cellular homolog of the viral oncoprotein v-jun. The viral homolog v-jun was discovered in avian sarcoma virus 17 and was named for ju-nana, the Japanese word for 17. The human JUN encodes a protein that is highly similar to the viral protein, which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies.

<span class="mw-page-title-main">Nuclear receptor 4A1</span> Mammalian protein found in Homo sapiens

The nuclear receptor 4A1 also known as Nur77, TR3, and NGFI-B is a protein that in humans is encoded by the NR4A1 gene.

<span class="mw-page-title-main">MYC</span> Protein-coding gene in the species Homo sapiens

MYC proto-oncogene, bHLH transcription factor is a protein that in humans is encoded by the MYC gene which is a member of the myc family of transcription factors. The protein contains basic helix-loop-helix (bHLH) structural motif.

<span class="mw-page-title-main">RUNX3</span> Protein-coding gene in humans

Runt-related transcription factor 3 is a protein that in humans is encoded by the RUNX3 gene.

<span class="mw-page-title-main">BCL3</span> Protein-coding gene in the species Homo sapiens

B-cell lymphoma 3-encoded protein is a protein that in humans is encoded by the BCL3 gene.

<span class="mw-page-title-main">KLF4</span> Protein-coding gene in the species Homo sapiens

Kruppel-like factor 4 is a member of the KLF family of zinc finger transcription factors, which belongs to the relatively large family of SP1-like transcription factors. KLF4 is involved in the regulation of proliferation, differentiation, apoptosis and somatic cell reprogramming. Evidence also suggests that KLF4 is a tumor suppressor in certain cancers, including colorectal cancer. It has three C2H2-zinc fingers at its carboxyl terminus that are closely related to another KLF, KLF2. It has two nuclear localization sequences that signals it to localize to the nucleus. In embryonic stem cells (ESCs), KLF4 has been demonstrated to be a good indicator of stem-like capacity. It is suggested that the same is true in mesenchymal stem cells (MSCs).

<span class="mw-page-title-main">FGF7</span> Protein-coding gene in the species Homo sapiens

Keratinocyte growth factor is a protein that in humans is encoded by the FGF7 gene.

<span class="mw-page-title-main">PIM1</span> Protein-coding gene in the species Homo sapiens

Proto-oncogene serine/threonine-protein kinase Pim-1 is an enzyme that in humans is encoded by the PIM1 gene.

<span class="mw-page-title-main">Secreted frizzled-related protein 1</span> Protein-coding gene in the species Homo sapiens

Secreted frizzled-related protein 1, also known as SFRP1, is a protein which in humans is encoded by the SFRP1 gene.

<span class="mw-page-title-main">WNT3A</span> Protein-coding gene in the species Homo sapiens

Protein Wnt-3a is a protein that in humans is encoded by the WNT3A gene.

<span class="mw-page-title-main">KLF10</span> Protein-coding gene in the species Homo sapiens

Krueppel-like factor 10 is a protein that in humans is encoded by the KLF10 gene.

<span class="mw-page-title-main">WNT1-inducible-signaling pathway protein 1</span> Protein-coding gene in the species Homo sapiens

WNT1-inducible-signaling pathway protein 1 (WISP-1), also known as CCN4, is a matricellular protein that in humans is encoded by the WISP1 gene.

<span class="mw-page-title-main">ASCL2</span> Protein-coding gene in humans

Achaete-scute complex homolog 2 (Drosophila), also known as ASCL2, is an imprinted human gene.

<span class="mw-page-title-main">WNT16</span> Mammalian protein found in Homo sapiens

Protein Wnt-16 is a protein that in humans is encoded by the WNT16 gene. It has been proposed that stimulation of WNT16 expression in nearby normal cells is responsible for the development of chemotherapy-resistance in cancer cells.

Ze’ev Ronai is an Israeli-American cancer research scientist and Chief Scientific Advisor at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla.

References

  1. 1 2 "ACGT - Scientific Advisory Council - Stuart A. Aaronson, M.D." Archived from the original on June 5, 2013. Retrieved 2010-01-06.
  2. 1 2 "Breast Cancer Research Foundation: Stuart Aaronson". Archived from the original on June 20, 2010. Retrieved 2010-01-06.
  3. 1 2 3 4 "The Mount Sinai Hospital - Faculty profile" . Retrieved 2010-01-06.
  4. 1 2 "The Black Family Stem Cell Institute" . Retrieved 2010-01-06.
  5. "Human Keratinocyte Growth Factor (KGF) from GenWay Biotech, Inc". Biocompare. Retrieved 2010-01-06.
  6. Ulich, T. R.; Yi, E. S.; Cardiff, R.; Yin, S.; Bikhazi, N.; Biltz, R.; Morris, C. F.; Pierce, G. F. (May 1994). "Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor". The American Journal of Pathology. 144 (5): 862–868. PMC   1887355 . PMID   8178937.
  7. "Retraction Watch Database".
  8. "United States Patent: 6479255".
  9. "United States Patent: 6225088".
  10. "United States Patent: 6228600".
  11. "United States Patent: 6403769".
  12. "United States Patent: 6566098".
  13. "United States Patent: 6639060".
  14. "United States Patent: 6653084".
  15. "United States Patent: 6660488".
  16. "United States Patent: 6709842".
  17. "United States Patent: 6833132".